Sugi Predict

Sugi Predict / Compounds / SCHEMBL1781629

SCHEMBL1781629

SCHEMBL1781629

CC(C)(C)c1cc(Br)c2c(c1)C(C)(C)c1cc(C(C)(C)C)cc(P(c3ccccc3)c3ccccc3)c1O2

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ DRD1 P21728 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL708320 0.92 DRD1 (0.61) DRD1
SCHEMBL16512009 0.87 DRD1 (0.56) DRD1
SCHEMBL21111854 0.86 DRD1 (0.55) DRD1
SCHEMBL29501658 0.86 DRD1 (0.55) DRD1
SCHEMBL29501652 0.86 DRD1 (0.55) DRD1
SCHEMBL21111888 0.85 DRD1 (0.57) DRD1
SCHEMBL16512415 0.84 DRD1 (0.52) DRD1
SCHEMBL21111795 0.83 DRD1 (0.51) DRD1
SCHEMBL21111784 0.83 DRD1 (0.51) DRD1
SCHEMBL29501639 0.83 DRD1 (0.51) DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212339-B1 BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS SOLVIAS AG (CH) 2018-01-10 — — EP disclosed
US-20150280150-A1 BI-, TRI- OR TETRANUCLEAR MIXED METAL COMPLEXES CONTAINING GROUP IB AND IVA ELEMENTS FOR ELECTRONIC DEVICES SUCH AS OLEDS MERCK PATENT GMBH (DE) 2015-10-01 — — US disclosed
US-20150280150-A1 BI-, TRI- OR TETRANUCLEAR MIXED METAL COMPLEXES CONTAINING GROUP IB AND IVA ELEMENTS FOR ELECTRONIC DEVICES SUCH AS OLEDS MERCK PATENT GMBH (DE) 2015-10-01 — — US disclosed
WO-2014067617-A1 BI-, TRI- OR TETRANUCLEAR MIXED METAL COMPLEXES CONTAINING GROUP IB AND IVA ELEMENTS FOR ELECTRONIC DEVICES SUCH AS OLEDS MERCK PATENT GMBH (DE) 2014-05-08 — — WO disclosed
US-8598371-B2 Bidentate chiral ligands for use in catalytic asymmetric addition reactions SOLVIAS AG (CH) 2013-12-03 — — US disclosed
US-20130267714-A1 BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS SOLVIAS AG (CH) 2013-10-10 — — US disclosed
US-8450501-B2 Bidentate chiral ligands for use in catalytic asymmetric addition reactions SOLVIAS AG (CH) 2013-05-28 — — US disclosed
WO-2011152358-A1 MEMBRANE CONTAINING SILVER COMPLEX 住友化学株式会社 (JP) 2011-12-08 — — WO disclosed
US-20110118482-A1 BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS SOLVIAS AG 2011-05-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150280150-A1 BI-, TRI- OR TETRANUCLEAR MIXED METAL COMPLEXES CONTAINING GROUP IB AND IVA ELEMENTS FOR ELECTRONIC DEVICES SUCH AS OLEDS OCIAD2, OCIAD1, INTS9 DRD1 636/4885
US-20130267714-A1 BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS C1R, PNISR, CBR1 DRD1 641/4885
US-20110118482-A1 BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS H1-2, H1-0, C1R DRD1 938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.